Mintz has advised Guggenheim Securities as placement agent on the deal. CalciMedica, Inc., a clinical-stage biopharmaceutical company, has entered into a definitive securities purchase agreement for...
CalciMedica Announces Private Placement of Up to $49 Million
Nyxoah Completes $95 Million Public Offering and Private Placement
NautaDutilh and Mintz have advised Nyxoah. Cleary Gottlieb Steen & Hamilton has represented the underwriters. Nyxoah, a medical technology company, has raised approximately USD 95 million...
Rallybio to Acquire Avenzo Therapeutics and Complete $215 Million Private Placement
Cooley has advised Avenzo Therapeutics. Ropes & Gray has advised Rallybio Corporation. Mintz has advised the placement agents. Rallybio Corporation has entered into a definitive agreement...
Satellos Bioscience Completes US$57.2 Million Cross-Border Public Offering and Nasdaq Listing
Mintz has advised Satellos Bioscience Inc. Latham & Watkins has represented the underwriters. Satellos Bioscience Inc., a clinical-stage biotechnology company, has completed a US$57.2 million underwritten...
Protara Therapeutics Prices $75 Million Public Offering
Kirkland & Ellis LLP has advised Protara Therapeutics, Inc. Mintz has advised the underwriters. Protara Therapeutics, Inc., a clinical-stage company focused on transformative therapies for cancer...
Wave Life Sciences Announces $402.5 Million Public Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, WongPartnership, and Choate Hall & Stewart have advised Wave Life Sciences. White & Case has advised the underwriters. Wave...
Precision BioSciences Announces $75 Million Registered Direct Offering
Latham & Watkins LLP has advised Precision BioSciences, Inc. Mintz has advised Guggenheim Securities, as the sole book-running manager. Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage...
Verastem Oncology Prices $90 Million Public Offering
Ropes & Gray has advised Verastem Oncology. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Verastem Oncology (Nasdaq: VSTM) has announced the...
MoonLake Immunotherapeutics Completes $75 Million Follow-on Equity Offering
Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised Leerink Partners. MoonLake Immunotherapeutics has completed the pricing of an...
Praxis Precision Medicines Completes $603 Million Public Offering
Latham & Watkins has advised Praxis Precision Medicines, Inc., and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo has advised the underwriters. Praxis Precision Medicines, Inc. (Nasdaq:...
Spruce Biosciences Announces $50 Million Private Placement Financing
Mintz has advised the placement agents. Spruce Biosciences, Inc. has entered into a definitive securities purchase agreement for a private placement expected to generate gross proceeds...
CAMP4 Secures Up to $100 Million Through Private Placement to Fund SYNGAP1 Clinical Program
Ropes & Gray has advised CAMP4 Therapeutics on the transaction, and Mintz has advised the placement agents. CAMP4 Therapeutics Corporation has announced a private placement transaction...